Kinase domain mutations in cancer: implications for small molecule drug design strategies.
Article Details
- CitationCopy to clipboard
Bikker JA, Brooijmans N, Wissner A, Mansour TS
Kinase domain mutations in cancer: implications for small molecule drug design strategies.
J Med Chem. 2009 Mar 26;52(6):1493-509. doi: 10.1021/jm8010542.
- PubMed ID
- 19239229 [ View in PubMed]
- Abstract
Not Available
DrugBank Data that Cites this Article
- Binding Properties
Drug Target Property Measurement pH Temperature (°C) Gefitinib Epidermal growth factor receptor Kd (nM) 35.3 N/A N/A Details